|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's Range||48.88 - 50.81|
|52 Week Range||20.98 - 55.31|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||55.00|
Castle will release its financial results for the third quarter ended Sept. 30, 2020, after the close of market on Monday, Nov. 9, 2020.
Castle today announced that it will host an investor webcast to highlight the planned launch of the ConfirmDx®-Melanoma test.
Zacks.com featured highlights include: Daqo, Surface Oncology, Covenant, Herc and Castle Biosciences